CAT No: CP25571
CAS No:201531-88-6
Synonyms/Alias:201531-88-6;Fmoc-Pen(Trt)-OH;FMOC-S-TRITYL-L-PENICILLAMINE;(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-methyl-3-(tritylthio)butanoicacid;(2R)-2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}-3-methyl-3-[(triphenylmethyl)sulfanyl]butanoicacid;Fmoc-pen(trt);SCHEMBL118262;CTK4E3419;MolPort-006-705-794;XSGMGAINOILNJR-PGUFJCEWSA-N;ACT10377;ANW-74539;MFCD00237388;ZINC71788116;AKOS015895566;RTX-012381;AK-48000;AN-30001;SC-26571;DB-038111;KB-254040;ST51052986;I06-1183;L-Valine,N-[(9H-fluoren-9-ylmethoxy)carbonyl]-3-[(triphenylmethyl)thio]-;(2R)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-methyl-3-tritylsulfanyl-butanoicacid
Chemical Name:N-alpha-(9-Fluorenylmethyloxycarbonyl)-S-trityl-L-penicillamine, Fmoc-beta,beta-dimethyl-L-Cys(Trt)-OH
1. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
5. Implications of ligand-receptor binding kinetics on GLP-1R signalling
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.